MedTrace Logo

Registry of the German CLL Study Group

NCT02863692 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2025-12-08

No results posted yet for this study

Summary

Long term follow-up of patients with chronic lymphocytic leukemia (CLL), B-prolymphocytic leukemia (B-PLL), T-cell prolymphocytic leukemia (T-PLL), Small lymphocytic lymphoma (SLL), T/Natural Killer large granular lymphocyte leukemia (T or NK-LGL), Hairy cell leukemia (HCL) and Richter's transformation

Conditions

  • Richter´s Transformation
  • CLL
  • SLL
  • HCL
  • Leukemia, Prolymphocytic, B-Cell
  • Leukemia, Prolymphocytic, T-Cell
  • T-LGL Leukemia
  • NK-LGL Leukemia

Sponsors & Collaborators

  • German CLL Study Group

    lead OTHER

Principal Investigators

  • Michael Hallek, MD · German CLL Study Group, Department I of Internal Medicine University Hospital Cologne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02863692 on ClinicalTrials.gov